Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:24 AM
Ignite Modification Date: 2025-12-25 @ 4:24 AM
NCT ID: NCT03108820
Eligibility Criteria: Inclusion Criteria: 1. English-speaking adult age 50 years and older; 2. admitted to Indiana University Health - Methodist or Eskenazi Health hospitals; 3. able to provide consent or has a legally authorized representative to provide consent; 4. access to a telephone; 5. and an injury severity score (ISS) of 9 or greater. Exclusion Criteria: 1. have a self-reported diagnosis of cancer with short life expectancy; 2. have a history of dementing illnesses and other neurodegenerative disease such as Alzheimer disease, Parkinson disease, or vascular dementia; 3. have a significant traumatic brain injury (defined as the presence of any intracranial blood on Computed Tomography scan of the head or best Glasgow Coma Scale Score of less than 13 at the time of study enrollment); 4. have any spinal cord injury with persistent neurologic deficit at the time of study enrollment; 5. are pregnant women (assessed by a urine pregnancy test); 6. have a primary residence outside the state of Indiana; 7. are incarcerated at the time of study enrollment; 8. have an acute stroke upon admission or develop a stroke as a new event during the course of hospitalization; 9. unable to complete study questionnaire due to severe hearing loss; 10. recent history of alcohol or substance abuse; 11. discharged to a permanent care facility; 12. admitted with a burn affecting \>10% total body surface area.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 50 Years
Study: NCT03108820
Study Brief:
Protocol Section: NCT03108820